De Felice, Kara Mari 2020. Patients Perception of Risks and Benefits of Biologic Therapy. Inflammatory bowel diseases, 26 1, 147-149
Nakanishi, Yukihiro; Jetly-Shridhar, Rachna; De Felice, Kara 2019. A Case of Pseudomelanosis Duodeni: Striking Endoscopic Features With Subtle but Characteristic Pathologic Findings. International journal of surgical pathology, 27 7, 765-766
Veerisetty, Sai S; Eschete, Stephanie O; Uhlhorn, Ann-Porter; De Felice, Kara M 2018. Women's Health in Inflammatory Bowel Disease. The American journal of the medical sciences, 356 3, 227-233
De Felice, K M; Novotna, M; Enders, F T; Faubion, W A; Tremaine, W J; Kantarci, O H; Raffals, L E 2015. Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients. Alimentary pharmacology & therapeutics, 41 1, 99-107
De Felice, Kara M; Gupta, Arjun; Rakshit, Sagar; Khanna, Sahil; Kottschade, Lisa A; Finnes, Heidi D; Papadakis, Konstantinos A; Loftus, Edward V; Raffals, Laura E; Markovic, Svetomir N 2015. Ipilimumab-induced colitis in patients with metastatic melanoma. Melanoma research, 25 4, 321-7
De Felice, Kara M; Katzka, David A; Raffals, Laura E 2015. Crohn's Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era. Inflammatory bowel diseases, 21 9, 2106-13
Gupta, A; De Felice, K M; Loftus, E V; Khanna, S 2015. Systematic review: colitis associated with anti-CTLA-4 therapy. Alimentary pharmacology & therapeutics, 42 4, 406-17
De Felice, Kara M; Kane, Sunanda V 2014. Inflammatory bowel disease in women of reproductive age. Expert review of gastroenterology & hepatology, 8 4, 417-25
